Thubrikar Aortic Valve Announces Authorization to Initiate Patient Implants Toward CE Mark Approval of Optimum TAV, and Development of Its Novel Precision 2 Delivery Catheter
Medtech Outlook recognized Thubrikar Aortic Valve as the exclusive recipient of “Top Aortic Valve Implantation System 2026,” and among the “Top Cardiovascular Device Companies”
Dr. Mano Thubrikar shares the story behind Thubrikar Aortic Valve’s mission to develop a more durable transcatheter aortic valve and discusses the latest progress of the Optimum TAVI System clinical trial
With their transcatheter aortic valve now ready to enter clinical trials, Thubrikar Aortic Valve is offering hope to patients with aortic valve disease for significantly reduced trauma, complications and recovery
